Label: ONCOPIG CANCER MODEL- oncopig not applicable
- NDC Code(s): 86150-0001-1
- Packager: Sus Clinicals, Inc
- Category: RECOMBINANT DEOXYRIBONUCLEIC ACID CONSTRUCT LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
Drug Label Information
Updated May 11, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine
-
INGREDIENTS AND APPEARANCE
ONCOPIG CANCER MODEL
oncopig not applicableProduct Information Product Type RECOMBINANT DEOXYRIBONUCLEIC ACID CONSTRUCT LABEL Item Code (Source) NDC:86150-0001 Route of Administration NOT APPLICABLE Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine (UNII: MT2ELV39H4) (Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine - UNII:MT2ELV39H4) Cre-inducible Neo-KRASG12D-TP53R167H rDNA construct in the ITPRID1 gene in cross-bred swine 1 [arb'U] in 1 [arb'U] Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:86150-0001-1 1 [arb'U] in 1 NOT APPLICABLE Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 12/09/2021 Labeler - Sus Clinicals, Inc (117539542) Registrant - Sus Clinicals, Inc (117539542) Establishment Name Address ID/FEI Business Operations University of Illinois Comparative Genomics Laboratory 118385427 manufacture Establishment Name Address ID/FEI Business Operations Oak Hill Genetics LLC 942380098 manufacture Establishment Name Address ID/FEI Business Operations Oak Hill Genetics LLC 118974584 manufacture